Literature DB >> 1361162

Fading responses in the evoked EMG after rocuronium in cats.

H Shiraishi1, H Suzuki, T Suzuki, N Katsumata, S Ogawa.   

Abstract

This study was performed to evaluate the inhibitory effect on motor nerve terminals by rocuronium using recovery curves of muscle compound action potentials (CAPs) and train-of-four ratios (TOFRs) in anaesthetized cats, and to compare the results with other relaxants reported previously. Recovery curves were derived from the amplitude of the CAP induced in the gastrocnemius muscle by the second of a paired stimulus (test response) to the sciatic nerve and compared with results evoked by the first component (conditioning response). The interval between the paired stimuli was increased stepwise from 7 to 1,000 msec, and the differences in amplitude of the test and conditioning responses were plotted on a graph by relating the changes in paired intervals. The recovery curve after rocuronium was less inhibited than after pancuronium, (100.4 +/- 5.9%, 82.3 +/- 6.7% and 68.5 +/- 6.7% at 60, 100 and 500 msec intervals, compared with 70.3 +/- 3.3%, 59.0 +/- 4.7% and 46.7 +/- 4.3% after pancuronium (P < 0.05). The recovery curves with d-tubocurarine were more depressed than with pancuronium; however, the RC with vecuronium was similar to that of rocuronium. The degree of fade in TOF by rocuronium was also less than those seen with d-tubocurarine and pancuronium. The results obtained suggest that rocuronium has less inhibitory effect on motor nerve terminals than do d-tubocurarine and pancuronium, and has a similar effect to that of vecuronium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361162     DOI: 10.1007/BF03008381

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  23 in total

1.  In vitro measurement of margin of safety of neuromuscular transmission.

Authors:  D R Waud; B E Waud
Journal:  Am J Physiol       Date:  1975-12

2.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.

Authors:  J M Wierda; U W Kleef; L M Lambalk; W D Kloppenburg; S Agoston
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

3.  Characteristics of nondepolarizing neuromuscular block: (I) post-junctional block by alpha-bungarotoxin.

Authors:  C Lee; D Chen; R L Katz
Journal:  Can Anaesth Soc J       Date:  1977-03

4.  An electromyographic study of muscle relaxants in man.

Authors:  H Suzuki; T Kanayama; H Nakagawa; S Yazaki; T Shiratsuchi
Journal:  Br J Anaesth       Date:  1975-05       Impact factor: 9.166

5.  Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.

Authors:  F M Gibson; R K Mirakhur
Journal:  Acta Anaesthesiol Scand       Date:  1989-04       Impact factor: 2.105

Review 6.  Prejunctional and postjunctional cholinoceptors at the neuromuscular junction.

Authors:  W C Bowman
Journal:  Anesth Analg       Date:  1980-12       Impact factor: 5.108

7.  Depression, facilitation, and mobilization of transmitter at the rat diaphragm neuromuscular junction.

Authors:  D F Wilson
Journal:  Am J Physiol       Date:  1979-07

8.  Prejunctional and postjunctional effects of tubocurarine and pancuronium in man.

Authors:  A Stanec; T Baker
Journal:  Br J Anaesth       Date:  1984-06       Impact factor: 9.166

9.  Absence of [125I] alpha-bungarotoxin binding to motor nerve terminals of frog, lizard and mouse muscle.

Authors:  S W Jones; M M Salpeter
Journal:  J Neurosci       Date:  1983-02       Impact factor: 6.167

10.  Neuromuscular effects of i.a. infusion of lignocaine in man.

Authors:  H Suzuki; S Yazaki; T Kanayama; H Nakagawa; S Ogawa; K Kuniyoshi; K Tai
Journal:  Br J Anaesth       Date:  1977-11       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.